VNRX — VOLITIONRX LTD
—
NYSE ·
Health Care ·
Life Sciences Tools & Services ·
CIK 93314 ·
Last close
$2.94
Market Cap
$24.49M
52W High
$6.00
52W Low
$1.91
ADV30
248,156
Next earnings
2026-08-13
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 985,076 | — | -5,228,321 | -6,664,774 | 9,036,483 | 3,102,817 | 42,396,412 |
| Dec 2025 | 447,034 | — | -4,731,280 | -6,270,832 | 6,901,227 | 1,117,028 | 42,494,038 |
| Sep 2025 | 627,277 | — | -4,868,806 | -5,378,358 | 6,448,885 | 199,407 | 42,398,447 |
| Jun 2025 | 406,688 | — | -6,221,816 | -6,284,078 | 8,704,790 | 2,255,996 | 41,803,112 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-19,683,334
Investing CF
$-89,558
Financing CF
$17,092,858
CapEx
$-287,417
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-4.80
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-252,901,370
Inventory
—
Receivables
$317,808
ST Investments
—
EBIT TTM
$-21,013,990
Pretax Income TTM
$-23,503,329
Interest Exp TTM
$2,489,339
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,727,384
EBITDA
$-20,754,864
Free Cash Flow
$-8,515,099
Enterprise Value
$24,849,408
Total Cash
$1,117,028
Total Debt
$11,464,730
Shares Out
8,330,270
Trailing EPS
$-4.25
Book Value
$-0.27
ROE
—
ROA
-166.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,727,384 | -21,222,056 | -23,357,027 | 6,901,227 | 42,494,038 | — | -19,683,334 |
| Dec 2024 | 1,233,511 | -26,921,602 | -26,967,836 | 9,399,523 | 35,507,259 | — | -25,893,624 |
| Dec 2023 | 775,302 | -35,773,244 | -35,319,078 | 27,950,498 | 36,662,720 | — | -18,062,999 |
| Dec 2022 | 306,392 | -30,550,647 | -30,268,793 | 18,295,054 | 21,422,016 | — | -15,277,742 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$10.80
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AWHL | Aspira Women's Health Inc. | $19.79M | $0.46 | — |
| QCLS | Q/C TECHNOLOGIES, INC. | $30.94M | $3.94 | — |
| TRIB | TRINITY BIOTECH PLC | $13.10M | $0.65 | — |
| ONMD | OneMedNet Corp | $48.17M | $0.88 | — |
| NYMXF | NYMOX PHARMACEUTICAL CORP | $12.29M | $0.13 | — |
News headlines (Yahoo Finance, 1h cache)
VolitionRx Limited (VNRX): 7 Best Rated Penny Stocks to Buy According to Wall Street Analysts
2026-05-24 11:49 · Yahoo
VolitionRX Ltd (VNRX) Q1 2026 Earnings Call Highlights: Revenue Surge and Strategic ...
2026-05-15 23:02 · Yahoo
VolitionRx Limited Announces First Quarter 2026 Financial Results and Business Update
2026-05-14 20:10 · Yahoo
VolitionRx Limited Schedules First Quarter 2026 Earnings Conference Call and Business Update
2026-05-11 12:19 · Yahoo
VolitionRx Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats
2026-05-06 12:17 · Yahoo
Volition Announces Breakthrough Finger-Prick Detection of Nucleosomes; Expanding Global Market Potential for Sepsis Testing
2026-04-29 12:17 · Yahoo
VNRX: Zacks SCR Refreshes its Latest Report With Volition's Financials, Prices, EPS Estimates, Market Statistics and Target Price Adjusted for 1-for-20 Reverse-Split
2026-04-28 09:10 · Yahoo
VNRX: Upcoming Milestones Expected in 2026; Year-End 2025 Results. Special Meeting of Stockholders Approves Reverse-Split. Subsequently, the Board of Directors authorized a 1-for-20 reverse-split that
2026-04-27 11:18 · Yahoo
VolitionRx Announces Acceptance of Compliance Plan by NYSE American
2026-04-23 12:12 · Yahoo
Volition Launches rNuQ™ Webshop Broadening Product Range
2026-04-20 11:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.